Form 4 for CYRX Cryoport, Inc.
Accepted 2023-03-24 00:00:00 ET · period of report 2023-03-22 · accession 0001104659-23-036713 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-24 | 2023-03-22 | CYRX | SHELTON JERRELL | CEO, Dir | A - Grant | $0.00 | +27.1K | 460.1K | +6% | $0 |
| D | 2023-03-24 | 2023-03-22 | CYRX | SHELTON JERRELL | CEO, Dir | A - Grant | $0.00 | +61.0K | 61.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-22 | A | A | 27,092 | $0.00 | 460,081 | D | — | — | (F1) Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. |
| 2 | Derivative | Stock Option (right to buy) | 2023-03-22 | A | A | 60,952 | $0.00 | 60,952 | D | $23.78 · — to 2030-03-22 | 60,952 Common Stock | (F2) 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023. |